PMID- 29423025 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20191120 IS - 1949-2553 (Electronic) IS - 1949-2553 (Linking) VI - 9 IP - 3 DP - 2018 Jan 9 TI - Methylseleninic acid induces NAD(P)H:quinone oxidoreductase-1 expression through activation of NF-E2-related factor 2 in Chang liver cells. PG - 3014-3028 LID - 10.18632/oncotarget.10289 [doi] AB - Selenium has been reported to induce the expression of some cytoprotective enzymes, which may account for its chemoprotective and chemopreventive effects. However, it remains largely unresolved whether these effects are exerted by selenium itself or mediated by its metabolite(s). In the present study, methylseleninic acid (MSeA), a monomethylated selenium, induced the expression of NAD(P)H:quinone oxidoreductase-1 (NQO-1) in human Chang liver cells. Expression of NQO-1 and other antioxidant/stress response genes is primarily regulated by the transcription factor NF-E2-related factor2 (Nrf2). Exposure of human Chang liver cells to MSeA (3 muM) increased nuclear translocation of Nrf2 and binding to antioxidant response elements. Silencing Nrf2 markedly reduced the MSeA-induced NQO-1 expression. In comparison with embryonic fibroblasts from Nrf2 wild-type mice, those from Nrf2 knockout mice failed to induce NQO-1 expression when treated with MSeA. Moreover, MSeA treatment enhanced ubiquitination of Keap1, but repressed Nrf2 ubiquitination. Pretreatment of cells with dithiothreitol abrogated the MSeA-induced NQO-1 expression, suggesting that MSeA causes Keap1 thiol modification. MSeA-induced NQO-1 upregulation was attenuated in cells harbouring the mutant Keap1 in which the cysteine 151 residue was replaced by serine. Oral administration of MSeA (1 mg/kg) by gavage to mice induced hepatic NQO-1 expression. Similar to MSeA, methylselenol generated from selenomethionine by methioninase activity induced NQO-1 expression. In conclusion, MSeA, the immediate precursor of methylselenol, upregulates the expression of NQO-1 via the Keap1-Nrf2 signaling. The above findings suggest that biological activities of selenium are dependent on the nature of the metabolites as well as the type of ingested selenium formulations. FAU - Park, Jong-Min AU - Park JM AD - Tumor Microenvironment Global Core Research Center and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul, South Korea. FAU - Kim, Do-Hee AU - Kim DH AD - Tumor Microenvironment Global Core Research Center and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul, South Korea. FAU - Na, Hye-Kyung AU - Na HK AD - Department of Food and Nutrition, College of Human Ecology, Sungshin Women's University, Seoul, South Korea. FAU - Surh, Young-Joon AU - Surh YJ AD - Tumor Microenvironment Global Core Research Center and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul, South Korea. AD - Cancer Research Institute, Seoul National University, Seoul, South Korea. LA - eng GR - 27302C0138/ES/NIEHS NIH HHS/United States PT - Journal Article DEP - 20160625 PL - United States TA - Oncotarget JT - Oncotarget JID - 101532965 PMC - PMC5790442 OTO - NOTNLM OT - Nrf2 OT - chemoprevention OT - methylseleninic acid OT - selenium COIS- CONFLICTS OF INTEREST The authors declare no conflicts of interest. EDAT- 2016/06/25 00:00 MHDA- 2016/06/25 00:01 PMCR- 2018/01/09 CRDT- 2018/02/10 06:00 PHST- 2015/11/01 00:00 [received] PHST- 2016/05/06 00:00 [accepted] PHST- 2018/02/10 06:00 [entrez] PHST- 2016/06/25 00:00 [pubmed] PHST- 2016/06/25 00:01 [medline] PHST- 2018/01/09 00:00 [pmc-release] AID - 10289 [pii] AID - 10.18632/oncotarget.10289 [doi] PST - epublish SO - Oncotarget. 2016 Jun 25;9(3):3014-3028. doi: 10.18632/oncotarget.10289. eCollection 2018 Jan 9.